Achieve Life Sciences (ACHV) Debt Ratio (2016 - 2026)

Achieve Life Sciences' (ACHV) quarterly Debt Ratio came in at 0.04 in Q4 2025, up 34.37% on a QoQ basis from 0.03 in Q3 2025.

Achieve Life Sciences (ACHV) Debt Ratio (2016 - 2026) Analysis & Trends

Achieve Life Sciences (ACHV) has 6 years of Debt Ratio data on file, last reported at 0.04 in Q4 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.04 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04 (changed N/A YoY) and the FY2025 annual result came in at 0.04, changed N/A from the prior year.
Debt Ratio rose to 0.04 in Q4 2025, from 0.03 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.79 in Q1 2023 to a low of 0.02 in Q2 2025.
A 4-year average of 0.21 and a median of 0.04 in 2025 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2023 — Debt Ratio sank 94.92% — and 2024, when it plunged 68.9%.
Tracing ACHV's Debt Ratio over 4 years: stood at 0.54 in 2022, then plunged by 94.92% to 0.03 in 2023, then soared by 398.52% to 0.14 in 2024, then slumped by 72.58% to 0.04 in 2025.
The last three Debt Ratio figures came in at 0.04 (Q4 2025), 0.03 (Q3 2025), and 0.02 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.05
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.12
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.47
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.26
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-	0.04

Download Data